Posted in | News

Gemma Power Systems Announces Receipt of EPC Contract for CPV Towantic Energy Center Project

Gemma Power Systems, LLC (GPS) has received Notice to Proceed (NTP) to commence activities under an Engineering, Procurement and Construction Agreement with Competitive Power Venture’s CPV Towantic Energy Center project (“CPV Towantic”) to construct a 785 MW state-of-the-art dual-fuel combined-cycle electric generating facility in Oxford, Connecticut.

CPV Towantic will be constructed on a 26-acre site and is scheduled to be completed in 2018. The CPV Towantic facility is a 2x1 combined-cycle project composed of two General Electric 7HA.01 combustion turbine generators, two heat recovery steam generators and one steam turbine generator. The primary fuel will be clean natural gas, however as required by the latest New England Independent System Operator requirements, the plant will be capable of operation on ultra-low sulfur distillate fuel oil.

“CPV is to be congratulated for bringing this project to fruition. CPV is a valued customer and we are pleased with the opportunity to continue our relationship by delivering another great project experience,” said William F. Griffin, Jr., Chief Executive Officer of Gemma Power Systems.

Most recently, Gemma successfully completed an 800 mw facility in Palm Springs, California for CPV.

About Gemma Power Systems

Gemma Power Systems, a wholly owned subsidiary of Argan Inc. (NYSE: AGX), is a leading Engineering, Procurement and Construction (EPC) company providing innovative solutions for the power and renewable energy industry. Our wide-ranging and comprehensive experience comprises 14,000 MW under contract and installed capacity including combined cycle and simple cycle gas turbine generating plants, biomass, solar facilities, wind farms, biofuel plants and environmental facilities. Additional information about Gemma Power Systems can be found at www.gemmapower.com. Follow Gemma on Twitter @gemmapwr.

Source: http://www.gemmapower.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.